Literature DB >> 22955928

HDAC6 controls the kinetics of platelet activation.

Karin Sadoul1, Jin Wang, Boubou Diagouraga, Anne-Laure Vitte, Thierry Buchou, Thérèse Rossini, Benoît Polack, Xiaodong Xi, Patrick Matthias, Saadi Khochbin.   

Abstract

HDAC6, a major cytoplasmic deacetylase, is shown here to fine-tune the kinetics of platelet activation, a process that must be precisely regulated to ensure hemostasis after blood vessel injury while preventing pathologic thrombus formation. The discoid shape of resting platelets in the circulation is maintained by several highly acetylated microtubules organized in a marginal band. During platelet activation, microtubules undergo major reorganizations, which contribute to the shape change of activating platelets. We show that, during these activation-induced shape changes, a dramatic HDAC6-mediated tubulin deacetylation takes place, followed by microtubule reacetylation in spread platelets. In addition, although HDAC6-controlled tubulin deacetylation is not required for platelet activation, the capacity of HDAC6 to prevent tubulin hyperacetylation influences the speed of platelet spreading. These results are particularly important in view of HDAC6 inhibitors being currently used in clinical trials and represent the first example of cell signaling by lysine acetylation in platelet biology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955928     DOI: 10.1182/blood-2012-05-428011

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation.

Authors:  Joseph E Aslan; Kevin G Phillips; Laura D Healy; Asako Itakura; Jiaqing Pang; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

2.  Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.

Authors:  Anh T P Ngo; Marisa L D Thierheimer; Özgün Babur; Anne D Rocheleau; Tao Huang; Jiaqing Pang; Rachel A Rigg; Annachiara Mitrugno; Dan Theodorescu; Julja Burchard; Xiaolin Nan; Emek Demir; Owen J T McCarty; Joseph E Aslan
Journal:  Am J Physiol Cell Physiol       Date:  2017-02-01       Impact factor: 4.249

3.  Sirtuin Inhibition Induces Apoptosis-like Changes in Platelets and Thrombocytopenia.

Authors:  Sharda Kumari; Susheel N Chaurasia; Manasa K Nayak; Ram L Mallick; Debabrata Dash
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

4.  Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Authors:  Nicholas A Vitanza; Matt C Biery; Carrie Myers; Eric Ferguson; Ye Zheng; Emily J Girard; Justyna M Przystal; Giulia Park; Alyssa Noll; Fiona Pakiam; Conrad A Winter; Shelli M Morris; Jay Sarthy; Bonnie L Cole; Sarah E S Leary; Courtney Crane; Nicole A P Lieberman; Sabine Mueller; Javad Nazarian; Raphael Gottardo; Mi-Youn Brusniak; Andrew J Mhyre; James M Olson
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

5.  Lysine acetyltransfer supports platelet function.

Authors:  J E Aslan; R A Rigg; M S Nowak; C P Loren; S M Baker-Groberg; J Pang; L L David; O J T McCarty
Journal:  J Thromb Haemost       Date:  2015-08-29       Impact factor: 5.824

Review 6.  Tubulin acetylation: responsible enzymes, biological functions and human diseases.

Authors:  Lin Li; Xiang-Jiao Yang
Journal:  Cell Mol Life Sci       Date:  2015-07-31       Impact factor: 9.261

7.  Mice lacking α-tubulin acetyltransferase 1 are viable but display α-tubulin acetylation deficiency and dentate gyrus distortion.

Authors:  Go-Woon Kim; Lin Li; Mohammad Ghorbani; Linya You; Xiang-Jiao Yang
Journal:  J Biol Chem       Date:  2013-05-28       Impact factor: 5.157

8.  Whole-genome sequencing of patients with rare diseases in a national health system.

Authors:  Ernest Turro; William J Astle; Karyn Megy; Stefan Gräf; Daniel Greene; Olga Shamardina; Hana Lango Allen; Alba Sanchis-Juan; Mattia Frontini; Chantal Thys; Jonathan Stephens; Rutendo Mapeta; Oliver S Burren; Kate Downes; Matthias Haimel; Salih Tuna; Sri V V Deevi; Timothy J Aitman; David L Bennett; Paul Calleja; Keren Carss; Mark J Caulfield; Patrick F Chinnery; Peter H Dixon; Daniel P Gale; Roger James; Ania Koziell; Michael A Laffan; Adam P Levine; Eamonn R Maher; Hugh S Markus; Joannella Morales; Nicholas W Morrell; Andrew D Mumford; Elizabeth Ormondroyd; Stuart Rankin; Augusto Rendon; Sylvia Richardson; Irene Roberts; Noemi B A Roy; Moin A Saleem; Kenneth G C Smith; Hannah Stark; Rhea Y Y Tan; Andreas C Themistocleous; Adrian J Thrasher; Hugh Watkins; Andrew R Webster; Martin R Wilkins; Catherine Williamson; James Whitworth; Sean Humphray; David R Bentley; Nathalie Kingston; Neil Walker; John R Bradley; Sofie Ashford; Christopher J Penkett; Kathleen Freson; Kathleen E Stirrups; F Lucy Raymond; Willem H Ouwehand
Journal:  Nature       Date:  2020-06-24       Impact factor: 49.962

9.  Nicergoline inhibits human platelet Ca(2+) signalling through triggering a microtubule-dependent reorganization of the platelet ultrastructure.

Authors:  T Walford; F I Musa; A G S Harper
Journal:  Br J Pharmacol       Date:  2015-12-05       Impact factor: 8.739

Review 10.  HDAC6 and ovarian cancer.

Authors:  Joshua Haakenson; Xiaohong Zhang
Journal:  Int J Mol Sci       Date:  2013-05-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.